v3.25.2
Net Loss Per Share Attributable to Common Shareholders (Tables)
12 Months Ended
Apr. 30, 2025
Earnings Per Share [Abstract]  
Schedule of Computation of Basic and Diluted Net Loss Per Share Attributable to Common Shareholders

The following table sets forth the computation of basic and diluted net loss per share attributable to common shareholders for the years ended April 30, 2025 and 2024:

 

Year Ended April 30,

 

 

2025

 

 

2024

 

Numerator:

 

 

 

 

 

Net loss attributable to Kestra Medical Technologies, Ltd.

$

(113,814

)

 

$

(94,120

)

Undeclared preferred dividends

 

(12,321

)

 

 

(6,721

)

Net loss attributable to common shareholders

$

(126,135

)

 

$

(100,841

)

Denominator:

 

 

 

 

 

Weighted average shares of common share outstanding

 

 

 

 

 

– basic and diluted

 

24,583,745

 

 

 

19,885,382

 

Net loss per share attributable to common shareholders

 

 

 

 

 

– basic and diluted

$

(5.13

)

 

$

(5.07

)